Spasfon



Indications and Reactions:

Role Indications Reactions
Primary
Anaemia 28.6%
Infertility 28.6%
Gestational Diabetes 14.3%
High Risk Pregnancy 14.3%
Urinary Tract Infection 14.3%
Maternal Drugs Affecting Foetus 50.0%
Urethral Dilatation 50.0%
Secondary
Product Used For Unknown Indication 43.6%
Drug Use For Unknown Indication 15.1%
Bipolar I Disorder 5.8%
Drug Exposure During Pregnancy 5.2%
Cholelithiasis 4.2%
Cholecystectomy 3.9%
Influenza 3.5%
Anaesthesia 2.5%
Gastroenteritis 2.1%
Vomiting 2.0%
Abdominal Pain 1.8%
Haemorrhoids 1.7%
Pain 1.6%
Pyrexia 1.5%
Prophylaxis 1.1%
Gastrointestinal Disorder 1.0%
Poisoning Deliberate 1.0%
Urinary Tract Infection 0.9%
Diarrhoea 0.8%
Anxiety 0.7%
Toxic Epidermal Necrolysis 15.3%
Stevens-johnson Syndrome 9.2%
Grand Mal Convulsion 7.1%
Toxic Skin Eruption 7.1%
Cytolytic Hepatitis 6.1%
Drug Rash With Eosinophilia And Systemic Symptoms 5.1%
Premature Baby 5.1%
Renal Failure Acute 5.1%
Leukopenia 4.1%
Malaise 4.1%
Urticaria 4.1%
Acute Generalised Exanthematous Pustulosis 3.1%
Agranulocytosis 3.1%
Gamma-glutamyltransferase Increased 3.1%
Hepatocellular Injury 3.1%
Lung Disorder 3.1%
Purpura 3.1%
Rash 3.1%
Septic Shock 3.1%
Staphylococcal Infection 3.1%
Concomitant
Drug Use For Unknown Indication 23.8%
Product Used For Unknown Indication 21.2%
Pain 7.7%
Crohn's Disease 6.7%
Hypertension 4.9%
Hiv Infection 4.8%
Abdominal Pain 4.8%
Prophylaxis 3.9%
Sarcoma 3.4%
Anxiety 2.6%
Nausea 2.1%
Thrombosis Prophylaxis 2.0%
Depression 1.8%
Constipation 1.7%
Pyrexia 1.7%
Antiviral Treatment 1.5%
Acute Myeloid Leukaemia 1.4%
Insomnia 1.4%
Colitis Ulcerative 1.3%
Colorectal Cancer Metastatic 1.3%
Thrombocytopenia 12.1%
Vomiting 10.7%
Renal Failure Acute 10.0%
Cytolytic Hepatitis 6.4%
Rhabdomyolysis 5.0%
Sepsis 5.0%
Weight Decreased 5.0%
Neutropenia 4.6%
Pyrexia 4.3%
General Physical Health Deterioration 3.9%
Subileus 3.9%
Hyponatraemia 3.6%
Pulmonary Embolism 3.6%
Vertigo 3.6%
Pancreatitis 3.2%
Rectal Haemorrhage 3.2%
Toxoplasmosis 3.2%
Cholestasis 2.9%
Lung Disorder 2.9%
Urinary Retention 2.9%
Interacting
Product Used For Unknown Indication 100.0%
Pancreatitis Acute 100.0%